MIND Collaborative

Mental Innovation and Neural Development

The Brain is the Last Frontier in Healthcare

Brain and mental health are universal human needs. We are investing in them to save lives and improve quality of life for billions of people worldwide.

1 in 5

1B+

People worldwide live with a mental health condition (WHO)

US adults suffer from mental health conditions each year (NIH)

65MM

People worldwide are affected by a neurodegenerative disease (NIH)


What is Brain Health?

Anything that helps a person think more clearly, or feel mentally more stable, from technologies that maintain, enhance, or restore neurological and emotional function across the lifespan (excluding oncology); from AI-enabled software that assists a therapist to complex neurotech.

For Profit

Strategic investments in funds and companies spanning the full spectrum of brain health.

  • Fund Investments

  • Direct Co-Investments

  • Special Situations

This initiative will deploy capital from investors who view brain health as both a return opportunity and a personal mission.

Nonprofit

High-impact grants, convening experts across disciplines, advocating for technology- and care-enabling reform.

  • Foundations

  • Donor-Advised Funds

  • Research Institutions

7Two MIND will partner with other philanthropic organizations supporting early-stage innovation and life-quality improving care.

Investment Strategy: A Dual-Track Approach

Best-in-Class Private Markets Managers

Allocating capital to venture and growth equity funds that give us access to companies and deep domain expertise in:

  • Mental Health

  • Neuroscience

  • Healthcare Innovation

  • Medical Devices

Direct Investment in Founders

Backing exceptional founders who define new categories and standards of care, focusing on:

  • Preventative brain health & cognitive resilience

  • Diagnostics, biomarkers, & neuro-data infrastructure

  • Employer & population-level mental health solutions

  • Digital mental health platforms & care delivery

  • Therapeutics, psychedelics, & novel treatment modalities

  • Neurodegenerative disease & neurological disorders

Investing Partners